Search Results - "Dellinger, Thanh H."

ASO Author Reflections: PIPAC Oxaliplatin in Refractory Colorectal or Appendiceal Carcinomatosis: Encouraging Results from a Phase 1 Clinical Trial by Sullivan, Kevin M., Dellinger, Thanh H., Raoof, Mustafa

Get full text

Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models by Roberts, Cai M, Shahin, Sophia Allaf, Wen, Wei, Finlay, James B, Dong, Juyao, Wang, Ruining, Dellinger, Thanh H, Zink, Jeffrey I, Tamanoi, Fuyuhiko, Glackin, Carlotta A

“…Abstract Epithelial ovarian cancer (EOC) is the most deadly gynecologic malignancy on account of its late stage at diagnosis and frequency of drug resistant…”
Get full text

L1CAM is an independent predictor of poor survival in endometrial cancer — An analysis of The Cancer Genome Atlas (TCGA) by Dellinger, Thanh H, Smith, David D, Ouyang, Ching, Warden, Charles D, Williams, John C, Han, Ernest S

“…Abstract Background L1-cell adhesion molecule (L1CAM) was previously reported to carry a poor prognosis in Stage I, low-risk endometrial cancer (EC). We…”
Get full text

Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer by Wen, Wei, Wu, Jun, Liu, Lucy, Tian, Yan, Buettner, Ralf, Hsieh, Meng-Yin, Horne, David, Dellinger, Thanh H, Han, Ernest S, Jove, Richard, Yim, John H

“…The EGFR signaling pathway is frequently activated in human ovarian cancer and associated with poor prognosis. However, inhibition of EGFR signaling in…”
Get full text

Pterostilbene in Cancer Therapy by Obrador, Elena, Salvador-Palmer, Rosario, Jihad-Jebbar, Ali, López-Blanch, Rafael, Dellinger, Thanh H, Dellinger, Ryan W, Estrela, José M

“…Natural polyphenols are organic chemicals which contain phenol units in their structures and possess antitumor properties. However, a key problem is their…”
Get full text

Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer by Wen, Wei, Liang, Wei, Wu, Jun, Kowolik, Claudia M, Buettner, Ralf, Scuto, Anna, Hsieh, Meng-Yin, Hong, Hao, Brown, Christine E, Forman, Stephen J, Horne, David, Morgan, Robert, Wakabayashi, Mark, Dellinger, Thanh H, Han, Ernest S, Yim, John H, Jove, Richard

“…JAK/STAT3 is one of the major signaling pathways that is aberrantly activated in ovarian cancer and associated with tumor progression and poor prognosis in…”
Get full text

Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer by Yang, Chunmei, Lee, Heehyoung, Jove, Veronica, Deng, Jiehui, Zhang, Wang, Liu, Xueli, Forman, Stephen, Dellinger, Thanh H, Wakabayashi, Mark, Yu, Hua, Pal, Sumanta

“…Several previous studies have identified a strong association between T-cell infiltration and clinical outcome in ovarian cancer. The role of B-cells remains…”
Get full text

Gynecologic Organ Preservation or Resection During CRS/HIPEC for GI Cancers by Dellinger, Thanh H.

Get full text

Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer by Mooney, Rachael, Majid, Asma Abdul, Batalla-Covello, Jennifer, Machado, Diana, Liu, Xueli, Gonzaga, Joanna, Tirughana, Revathiswari, Hammad, Mohamed, Dellinger, Thanh H., Lesniak, Maciej S., Curiel, David T., Aboody, Karen S.

“…Oncolytic virotherapy is a promising approach for treating recurrent and/or drug-resistant ovarian cancer. However, its successful application in the clinic…”
Get full text

HIPEC in the Consolidation Setting: A Consolation Prize for Chemorefractory Ovarian Cancer? by Dellinger, Thanh H.

Get full text

Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target by Roberts, Cai M, Shahin, Sophia A, Loeza, Joana, Dellinger, Thanh H, Williams, John C, Glackin, Carlotta A

“…Most cancer deaths result from tumor cells that have metastasized beyond their tissue of origin, or have developed drug resistance. Across many cancer types,…”
Get full text

Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer by Wen, Wei, Han, Ernest S., Dellinger, Thanh H., Wu, Jun, Guo, Yuming, Buettner, Ralf, Horne, David A., Jove, Richard, Yim, John H.

“…Many signaling pathways, including the JAK/STAT3 pathway, are aberrantly activated and associated with ovarian cancer growth and progression. However,…”
Get full text

Role of canonical Wnt signaling in endometrial carcinogenesis by Dellinger, Thanh H, Planutis, Kestutis, Tewari, Krishnansu S, Holcombe, Randall F

“…While the role of Wnt signaling is well established in colorectal carcinogenesis, its function in gynecologic cancers has not been elucidated. Here, we…”
Get full text

Neural Stem Cells Improve the Delivery of Oncolytic Chimeric Orthopoxvirus in a Metastatic Ovarian Cancer Model by Hammad, Mohamed, Cornejo, Yvonne R., Batalla-Covello, Jennifer, Majid, Asma Abdul, Burke, Connor, Liu, Zheng, Yuan, Yate-Ching, Li, Min, Dellinger, Thanh H., Lu, Jianming, Chen, Nanhai G., Fong, Yuman, Aboody, Karen S., Mooney, Rachael

“…Oncolytic virotherapy represents a promising approach for treating recurrent and/or drug-resistant ovarian cancer. However, its successful application in the…”
Get full text

Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and design by Raoof, Mustafa, Sullivan, Kevin M., Frankel, Paul H., Fakih, Marwan, Synold, Timothy W., Lim, Dean, Woo, Yanghee, Paz, Isaac Benjamin, Fong, Yuman, Thomas, Rebecca Meera, Chang, Sue, Eng, Melissa, Tinsley, Raechelle, Whelan, Richard L., Deperalta, Danielle, Reymond, Marc A., Jones, Jeremy, Merchea, Amit, Dellinger, Thanh H.

“…Peritoneal metastasis (PM) from appendiceal cancer or colorectal cancer (CRC) has significant morbidity and limited survival. Pressurized intraperitoneal…”
Get full text

Novel Chimeric Poxvirus CF17 Improves Survival in a Murine Model of Intraperitoneal Ovarian Cancer Metastasis by Hammad, Mohamed, Cornejo, Yvonne, Flores, Linda, Hyde, Caitlyn, Ngai, Hoi Wa, Li, Min, Dellinger, Thanh H., Lu, Jianming, Chen, Nanhai G., Mooney, Rachael, Aboody, Karen S., Fong, Yuman

“…Despite improvements in surgical techniques and chemotherapy, ovarian cancer remains the most lethal gynecologic cancer. Thus, there is an urgent need for more…”
Get full text

ASO Author Reflections: Preventing Nephrotoxicities in Ovarian Cancer Patients Undergoing HIPEC by Senguttuvan, Rosemary N., Dellinger, Thanh H.

Get full text

State of the Science: The role of HIPEC in the treatment of ovarian cancer by Dellinger, Thanh H., Han, Ernest S.

Get full text

Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial by Waheed, Muhammad Talha, Ruel, Nora, Whelan, Richard L., Fakih, Marwan, Fong, Yuman, Deperalta, Danielle, Merchea, Amit, Sun, Virginia, Krouse, Robert, Dellinger, Thanh H., Raoof, Mustafa

“…Background Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) is a novel, minimally invasive, safe, and repeatable method to treat carcinomatosis…”
Get full text

Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA by Raoof, Mustafa, Whelan, Richard L., Sullivan, Kevin M., Ruel, Christopher, Frankel, Paul H., Cole, Sarah E., Tinsley, Raechelle, Eng, Melissa, Fakih, Marwan, Chao, Joseph, Lim, Dean, Woo, Yanghee, Paz, Isaac Benjamin, Lew, Michael, Cristea, Michaela, Rodriguez-Rodriguez, Lorna, Fong, Yuman, Thomas, Rebecca Meera, Chang, Sue, Deperalta, Danielle, Merchea, Amit, Dellinger, Thanh H.

“…Background Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) is a laparoscopic locoregional treatment for peritoneal metastases (PM) from colorectal…”
Get full text